Cargando…
453 A 26-Year Review of Long-term Safety of a Human Pasteurized C1 Inhibitor Concentrate
BACKGROUND: Hereditary angioedema (HAE) is a rare disorder characterized by C1 inhibitor (C1-INH) deficiency, resulting in periodic attacks of acute edema. C1-INH replacement therapy is recommended as first-line therapy for treatment of acute HAE attacks, demonstrating rapid onset of symptom relief...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization Journal
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512953/ http://dx.doi.org/10.1097/01.WOX.0000412216.59928.8f |